The current valuation score of ABVC Biopharma Inc is 6.23, ranking 349 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.34, which is -93.19% below the recent high of -0.23 and -456.76% above the recent low of -18.59.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.